CBD-Associated EEG Connectivity Changes Were Not Themselves Seizure-Freedom Evidence

Changes in EEG connectivity after CBD are evidence about measured network activity, not automatically evidence of seizure freedom. A review describes connectivity findings in epileptic encephalopathy alongside clinical seizure studies, and the endpoints should remain distinct.

The network measure described organization

The review discusses abnormal synchronization across frequency bands in epileptic encephalopathy and reports CBD-associated changes toward a more integrated, less segregated network organization.

Such analyses can help investigate how brain activity changes during treatment. They do not directly count seizures, measure injury avoidance or establish quality-of-life improvement.

A candidate marker needs its own validation

A network change can be biologically interesting even when its relation to clinical benefit remains uncertain. Calling it normalization requires a defined comparison and does not establish that the entire disease process has normalized.

To use a connectivity measure as a treatment surrogate, evidence would need to connect changes in that measure with relevant clinical outcomes under appropriate conditions. The review summary alone does not establish that substitution.

Read the clinical and biomarker findings together

The same review describes controlled evidence for CBD in particular drug-resistant epilepsy syndromes. That clinical evidence should be evaluated on its own outcomes, rather than inferred from an EEG pattern.

Conversely, a favorable clinical response does not prove the proposed network mechanism. Separating mechanism, marker and patient outcome preserves the potential importance of the EEG research without assigning it a clinical meaning it has not independently demonstrated.

Related: Why outcomes must remain specific to the tested domain.

Research cited

Șolea R; Șerban E; Călugăr-Solea SF; et al.. Pharmaceuticals (2026). Cannabis and Cannabinoids: The Medical Potential of Cannabidiol in Mental and Neurological Disorders.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

MAGL Inhibition Rescued Selected Deficits After Adolescent Alcohol Exposure in Mice

A review describes MAGL inhibitors rescuing selected hippocampal and recognition-memory deficits after adolescent alcohol exposure in mice. The experiment concerns endogenous cannabinoid metabolism, not evidence that THC or marijuana reverses alcohol-related cognitive problems in people. The findings linked a circuit with a behavioral task Kunos’s 2020 review summarizes work in…

Spread the love

Read Article: MAGL Inhibition Rescued Selected Deficits After Adolescent Alcohol Exposure in Mice

Alcohol Pretreatment Did Not Produce a Dose-Dependent Increase in Cannabis Self-Administration

In a laboratory study summarized in a co-use review, increasing the alcohol pretreatment dose did not produce a dose-dependent change in subsequent cannabis self-administration. That result concerns motivation and consumption under the tested conditions, not the safety of combining the drugs. Participants could choose their cannabis intake Yurasek and colleagues’…

Spread the love

Read Article: Alcohol Pretreatment Did Not Produce a Dose-Dependent Increase in Cannabis Self-Administration

Propofol Can Alter Endocannabinoid Signaling During an Experiment

An anesthetic used during an experiment may influence the endocannabinoid system being studied. A review identifies propofol’s effects on FAAH and anandamide as a reason to record anesthesia when interpreting in-vivo cannabinoid research. The background drug can affect the pathway Basavarajappa and colleagues’ 2019 review describes propofol increasing anandamide through…

Spread the love

Read Article: Propofol Can Alter Endocannabinoid Signaling During an Experiment

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us